Algernon Pharmaceuticals Inc AGNPF

Primary Symbol: C.AGN

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc > Trading below PP

<< Previous

Bullboard Posts

Next >>

Comment by TheBearInTheWoodson Jul 09, 2022 2:47pm

92 Views

Post# 34813041

RE:RE:RE:RE:Trading below PP

TheBearInTheWoods wrote: When I was a newer investor, I used plays like AGN to learn. You can trade plays like AGN, But I dont invest in companies that Management doesnt.

Next time dont beat up on critical posts and take some time to do some research,

GLTA

TheBearInTheWoods wrote: Your correct, missed that NR. I stand by the rest of the post though, The company has 120 mil shares outstanding and 40 million warrants....

Comparing BLU and AGN is interesting

AGN - Rights?

Shares Outstanding - 120,000,000
Warrants Remaining - 40,000,000!!!
Insider Holding - 2%
Insider Buying - $30,000

BLU - Owns a Drug and Commercialization

Shares Outstanding - 60,000,000
Warrants Remaining - 0
Insider Holding - 33%
Insider Buying - $274,000

Lets Throw in ARCH for fun - Owns a Drug and Commercialization

Shares Outstanding - 58,000,000
Warrants Remaining - 0
Insider Holding - 55%
Insider Buying - $282,000

You can tell alot about how Management will treat you based on what they personally have in the play... These numbers speak for themselves.

One question I have with this play though, if someone can answer and provide a link is: Does AGN own a patent or License to distribute in Canada? BLU owns a drug and can commercialize it as does ARCH . AGN is repurposing a drug that has previously been approved in South korea and Japan decades ago, I have had difficulty digging up the rights AGN has to the drug itself.

Once again, I want you guys to make money I just like to dive into the details. Maybe I will buy some AGN but I cant find clarity on the rights and if AGN only has rights to Canada for instance than there isnt much of a market.